CommercialCoverageMedium impact
06.02.46a, Rapid Whole Exome Sequencing (rWES) and Rapid Whole Genome Sequencing (rWGS) for Diagnosis of Genetic Disorders
Independence Blue Cross·Genetics, Pediatrics, Internal Medicine +1 more·Medical Policy
Effective date
Jun 24, 2026
We identified it
Jun 25, 2026
Summary
Policy 06.02.46a regarding Rapid Whole Exome Sequencing (rWES) and Rapid Whole Genome Sequencing (rWGS) for diagnosis of genetic disorders has been reissued for commercial plans. This is a fresh policy update (1 day old) effective June 24, 2026. The billing team must review the full policy text to identify coverage criteria, prior authorization requirements, and applicable billing codes for genetic sequencing services.
Action Required
By June 24, 2026: Billing team must obtain and review the complete policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=06&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#commercial-06-02-46a to identify: (1) Specific CPT/HCPCS codes for rWES and rWGS services, (2) Prior authorization requirements and submission processes, (3) Medical necessity criteria for genetic testing, and (4) Any limitations or exclusions. Update billing software, encounter forms, and provider documentation templates accordingly. Communicate changes to providers and front desk staff to ensure proper authorization before ordering tests. Claims submitted without compliance to this policy may be denied.